Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$19.4K Hold
279
﹤0.01% 833
2025
Q4
$21.2K Sell
279
-1,795
-87% -$144K ﹤0.01% 502
2025
Q3
$179K Buy
+2,074
New +$156K 0.02% 156
2025
Q2
Sell
-10
Closed -$595 935
2025
Q1
$595 Hold
10
﹤0.01% 886
2024
Q4
$605 Hold
10
﹤0.01% 929
2024
Q3
$720 Hold
10
﹤0.01% 920
2024
Q2
$704 Hold
10
﹤0.01% 889
2024
Q1
$797 Hold
10
﹤0.01% 873
2023
Q4
$897 Hold
10
﹤0.01% 857
2023
Q3
$986 Hold
10
﹤0.01% 816
2023
Q2
$1.02K Hold
10
﹤0.01% 822
2023
Q1
$1.12K Hold
10
﹤0.01% 830
2022
Q4
$931 Hold
10
﹤0.01% 804
2022
Q3
$1K Hold
10
﹤0.01% 787
2022
Q2
$1K Hold
10
﹤0.01% 763
2022
Q1
$1K Buy
+10
New +$1.33K ﹤0.01% 752

Other funds holding APTV

McIlrath & Eck's APTV Position: Q1 2026 in Review

McIlrath & Eck held its Aptiv (APTV) position steady in Q1 2026 at 279 shares worth $19.4K. The position accounts for ﹤0.01% of the portfolio, ranked #833.

McIlrath & Eck first reported a position in APTV in Q1 2022 and has held it in 16 quarters since. The position peaked at $179K in Q3 2025. 710 funds tracked by Wall St. Rank hold APTV as of Q1 2026.

  • McIlrath & Eck held 279 shares of Aptiv worth $19.4K as of Q1 2026.
  • McIlrath & Eck left its Aptiv share count unchanged in Q1 2026.
  • Aptiv made up ﹤0.01% of McIlrath & Eck's portfolio in Q1 2026, its #833 holding.
  • McIlrath & Eck first reported a position in Aptiv in Q1 2022 and has held it in 16 quarters since.
  • McIlrath & Eck's Aptiv position peaked at $179K in Q3 2025.
  • 710 funds tracked by Wall St. Rank held Aptiv as of Q1 2026.

Based on McIlrath & Eck's 13F filing for Q1 2026, filed 19 May 2026.